Global Anti-Dermatomycosis Treatment Market Research Report 2024(Status and Outlook)

Global Anti-Dermatomycosis Treatment Market Research Report 2024(Status and Outlook)



Report Overview:

Dermatomycosis are infections of skin, nails, and hair which are caused by dermatophytes, yeasts and moulds.Anti-fungals are grouped in to three classes based on action like azoles (inhibit synthesis of Ergosterol), Polyenes (membrane sterols), and 5-Fluorocytosine (inhibits macromolecular synthesis).

The Global Anti-Dermatomycosis Treatment Market Size was estimated at USD 3156.64 million in 2023 and is projected to reach USD 4528.69 million by 2029, exhibiting a CAGR of 6.20% during the forecast period.

This report provides a deep insight into the global Anti-Dermatomycosis Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anti-Dermatomycosis Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anti-Dermatomycosis Treatment market in any manner.

Global Anti-Dermatomycosis Treatment Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Pfizer Inc.

Sanofi S.A.

Novatis AG

Mylan N.V.

Abbott Laboratories

Bayer AG

Eli Lilly and Company

AbbVie Inc.

Glaxosmithkline Plc

Janssen Pharmaceuticals, Inc.

Taro Pharmaceutical Industries Ltd.

Mayne Pharma Group Limited

Viamet Pharmaceuticals, Inc.

Scynexis Inc.

Enzon Pharmaceuticals

Gilead Sciences Inc.

Market Segmentation (by Type)

Polyens

Azoles

Allylamines

Echinocandins

Others

Market Segmentation (by Application)

Tinea Corporis

Tinea Unguium

Aspergillosis

Tinea Capitis

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Anti-Dermatomycosis Treatment Market

Overview of the regional outlook of the Anti-Dermatomycosis Treatment Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anti-Dermatomycosis Treatment Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Anti-Dermatomycosis Treatment
1.2 Key Market Segments
1.2.1 Anti-Dermatomycosis Treatment Segment by Type
1.2.2 Anti-Dermatomycosis Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Anti-Dermatomycosis Treatment Market Overview
2.1 Global Market Overview
2.1.1 Global Anti-Dermatomycosis Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Anti-Dermatomycosis Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Anti-Dermatomycosis Treatment Market Competitive Landscape
3.1 Global Anti-Dermatomycosis Treatment Sales by Manufacturers (2019-2024)
3.2 Global Anti-Dermatomycosis Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Anti-Dermatomycosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Anti-Dermatomycosis Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Anti-Dermatomycosis Treatment Sales Sites, Area Served, Product Type
3.6 Anti-Dermatomycosis Treatment Market Competitive Situation and Trends
3.6.1 Anti-Dermatomycosis Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Anti-Dermatomycosis Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Anti-Dermatomycosis Treatment Industry Chain Analysis
4.1 Anti-Dermatomycosis Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Anti-Dermatomycosis Treatment Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Anti-Dermatomycosis Treatment Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anti-Dermatomycosis Treatment Sales Market Share by Type (2019-2024)
6.3 Global Anti-Dermatomycosis Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Anti-Dermatomycosis Treatment Price by Type (2019-2024)
7 Anti-Dermatomycosis Treatment Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anti-Dermatomycosis Treatment Market Sales by Application (2019-2024)
7.3 Global Anti-Dermatomycosis Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Anti-Dermatomycosis Treatment Sales Growth Rate by Application (2019-2024)
8 Anti-Dermatomycosis Treatment Market Segmentation by Region
8.1 Global Anti-Dermatomycosis Treatment Sales by Region
8.1.1 Global Anti-Dermatomycosis Treatment Sales by Region
8.1.2 Global Anti-Dermatomycosis Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Anti-Dermatomycosis Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Anti-Dermatomycosis Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Anti-Dermatomycosis Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Anti-Dermatomycosis Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Anti-Dermatomycosis Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Pfizer Inc.
9.1.1 Pfizer Inc. Anti-Dermatomycosis Treatment Basic Information
9.1.2 Pfizer Inc. Anti-Dermatomycosis Treatment Product Overview
9.1.3 Pfizer Inc. Anti-Dermatomycosis Treatment Product Market Performance
9.1.4 Pfizer Inc. Business Overview
9.1.5 Pfizer Inc. Anti-Dermatomycosis Treatment SWOT Analysis
9.1.6 Pfizer Inc. Recent Developments
9.2 Sanofi S.A.
9.2.1 Sanofi S.A. Anti-Dermatomycosis Treatment Basic Information
9.2.2 Sanofi S.A. Anti-Dermatomycosis Treatment Product Overview
9.2.3 Sanofi S.A. Anti-Dermatomycosis Treatment Product Market Performance
9.2.4 Sanofi S.A. Business Overview
9.2.5 Sanofi S.A. Anti-Dermatomycosis Treatment SWOT Analysis
9.2.6 Sanofi S.A. Recent Developments
9.3 Novatis AG
9.3.1 Novatis AG Anti-Dermatomycosis Treatment Basic Information
9.3.2 Novatis AG Anti-Dermatomycosis Treatment Product Overview
9.3.3 Novatis AG Anti-Dermatomycosis Treatment Product Market Performance
9.3.4 Novatis AG Anti-Dermatomycosis Treatment SWOT Analysis
9.3.5 Novatis AG Business Overview
9.3.6 Novatis AG Recent Developments
9.4 Mylan N.V.
9.4.1 Mylan N.V. Anti-Dermatomycosis Treatment Basic Information
9.4.2 Mylan N.V. Anti-Dermatomycosis Treatment Product Overview
9.4.3 Mylan N.V. Anti-Dermatomycosis Treatment Product Market Performance
9.4.4 Mylan N.V. Business Overview
9.4.5 Mylan N.V. Recent Developments
9.5 Abbott Laboratories
9.5.1 Abbott Laboratories Anti-Dermatomycosis Treatment Basic Information
9.5.2 Abbott Laboratories Anti-Dermatomycosis Treatment Product Overview
9.5.3 Abbott Laboratories Anti-Dermatomycosis Treatment Product Market Performance
9.5.4 Abbott Laboratories Business Overview
9.5.5 Abbott Laboratories Recent Developments
9.6 Bayer AG
9.6.1 Bayer AG Anti-Dermatomycosis Treatment Basic Information
9.6.2 Bayer AG Anti-Dermatomycosis Treatment Product Overview
9.6.3 Bayer AG Anti-Dermatomycosis Treatment Product Market Performance
9.6.4 Bayer AG Business Overview
9.6.5 Bayer AG Recent Developments
9.7 Eli Lilly and Company
9.7.1 Eli Lilly and Company Anti-Dermatomycosis Treatment Basic Information
9.7.2 Eli Lilly and Company Anti-Dermatomycosis Treatment Product Overview
9.7.3 Eli Lilly and Company Anti-Dermatomycosis Treatment Product Market Performance
9.7.4 Eli Lilly and Company Business Overview
9.7.5 Eli Lilly and Company Recent Developments
9.8 AbbVie Inc.
9.8.1 AbbVie Inc. Anti-Dermatomycosis Treatment Basic Information
9.8.2 AbbVie Inc. Anti-Dermatomycosis Treatment Product Overview
9.8.3 AbbVie Inc. Anti-Dermatomycosis Treatment Product Market Performance
9.8.4 AbbVie Inc. Business Overview
9.8.5 AbbVie Inc. Recent Developments
9.9 Glaxosmithkline Plc
9.9.1 Glaxosmithkline Plc Anti-Dermatomycosis Treatment Basic Information
9.9.2 Glaxosmithkline Plc Anti-Dermatomycosis Treatment Product Overview
9.9.3 Glaxosmithkline Plc Anti-Dermatomycosis Treatment Product Market Performance
9.9.4 Glaxosmithkline Plc Business Overview
9.9.5 Glaxosmithkline Plc Recent Developments
9.10 Janssen Pharmaceuticals, Inc.
9.10.1 Janssen Pharmaceuticals, Inc. Anti-Dermatomycosis Treatment Basic Information
9.10.2 Janssen Pharmaceuticals, Inc. Anti-Dermatomycosis Treatment Product Overview
9.10.3 Janssen Pharmaceuticals, Inc. Anti-Dermatomycosis Treatment Product Market Performance
9.10.4 Janssen Pharmaceuticals, Inc. Business Overview
9.10.5 Janssen Pharmaceuticals, Inc. Recent Developments
9.11 Taro Pharmaceutical Industries Ltd.
9.11.1 Taro Pharmaceutical Industries Ltd. Anti-Dermatomycosis Treatment Basic Information
9.11.2 Taro Pharmaceutical Industries Ltd. Anti-Dermatomycosis Treatment Product Overview
9.11.3 Taro Pharmaceutical Industries Ltd. Anti-Dermatomycosis Treatment Product Market Performance
9.11.4 Taro Pharmaceutical Industries Ltd. Business Overview
9.11.5 Taro Pharmaceutical Industries Ltd. Recent Developments
9.12 Mayne Pharma Group Limited
9.12.1 Mayne Pharma Group Limited Anti-Dermatomycosis Treatment Basic Information
9.12.2 Mayne Pharma Group Limited Anti-Dermatomycosis Treatment Product Overview
9.12.3 Mayne Pharma Group Limited Anti-Dermatomycosis Treatment Product Market Performance
9.12.4 Mayne Pharma Group Limited Business Overview
9.12.5 Mayne Pharma Group Limited Recent Developments
9.13 Viamet Pharmaceuticals, Inc.
9.13.1 Viamet Pharmaceuticals, Inc. Anti-Dermatomycosis Treatment Basic Information
9.13.2 Viamet Pharmaceuticals, Inc. Anti-Dermatomycosis Treatment Product Overview
9.13.3 Viamet Pharmaceuticals, Inc. Anti-Dermatomycosis Treatment Product Market Performance
9.13.4 Viamet Pharmaceuticals, Inc. Business Overview
9.13.5 Viamet Pharmaceuticals, Inc. Recent Developments
9.14 Scynexis Inc.
9.14.1 Scynexis Inc. Anti-Dermatomycosis Treatment Basic Information
9.14.2 Scynexis Inc. Anti-Dermatomycosis Treatment Product Overview
9.14.3 Scynexis Inc. Anti-Dermatomycosis Treatment Product Market Performance
9.14.4 Scynexis Inc. Business Overview
9.14.5 Scynexis Inc. Recent Developments
9.15 Enzon Pharmaceuticals
9.15.1 Enzon Pharmaceuticals Anti-Dermatomycosis Treatment Basic Information
9.15.2 Enzon Pharmaceuticals Anti-Dermatomycosis Treatment Product Overview
9.15.3 Enzon Pharmaceuticals Anti-Dermatomycosis Treatment Product Market Performance
9.15.4 Enzon Pharmaceuticals Business Overview
9.15.5 Enzon Pharmaceuticals Recent Developments
9.16 Gilead Sciences Inc.
9.16.1 Gilead Sciences Inc. Anti-Dermatomycosis Treatment Basic Information
9.16.2 Gilead Sciences Inc. Anti-Dermatomycosis Treatment Product Overview
9.16.3 Gilead Sciences Inc. Anti-Dermatomycosis Treatment Product Market Performance
9.16.4 Gilead Sciences Inc. Business Overview
9.16.5 Gilead Sciences Inc. Recent Developments
10 Anti-Dermatomycosis Treatment Market Forecast by Region
10.1 Global Anti-Dermatomycosis Treatment Market Size Forecast
10.2 Global Anti-Dermatomycosis Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Anti-Dermatomycosis Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Anti-Dermatomycosis Treatment Market Size Forecast by Region
10.2.4 South America Anti-Dermatomycosis Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Anti-Dermatomycosis Treatment by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Anti-Dermatomycosis Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Anti-Dermatomycosis Treatment by Type (2025-2030)
11.1.2 Global Anti-Dermatomycosis Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Anti-Dermatomycosis Treatment by Type (2025-2030)
11.2 Global Anti-Dermatomycosis Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Anti-Dermatomycosis Treatment Sales (K Units) Forecast by Application
11.2.2 Global Anti-Dermatomycosis Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings